Macrophage mannose receptor (MR) participates in pathogen recognition, clearance of endogenous serum glycoproteins and antigen presentation. MR is also present on lymphatic vessels, where its function is unknown. Here we show that migration of lymphocytes from the skin into the draining lymph nodes through the afferent lymphatics is reduced in MRdeficient mice, whilst the structure of lymphatic vasculature remains normal in these animals. Moreover, in a tumor model the primary tumors grow significantly bigger in MR-/-mice than in the wild-type (WT) controls, whereas the regional lymph node metastases are markedly smaller. Adhesion of both normal lymphocytes and tumor cells to lymphatic vessels is significantly decreased in MR deficient mice. Ability of macrophages to present tumor antigens is indistinguishable between the two genotypes. Thus, MR on lymphatic endothelial cells is involved in leukocyte trafficking and contributes to the metastatic behavior of cancer cells. Blocking of MR may provide a new approach to controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
Introduction
Molecular mechanisms regulating lymphocyte entry from the blood into the lymphoid tissues during their recirculation are well characterized. 1, 2 In contrast, much less is known about the exit mechanisms of leukocytes from the peripheral tissues into the afferent lymphatics and from the lymphoid organs into efferent lymphatics, although lymphocyte and dendritic cell migration via the lymphatics is essential for controlling the nature and magnitude of immune responses. 3 Moreover, lymphatics are important routes for metastasis of different types of cancers. For example, breast cancers and squamocellular cancers in the head and neck area mainly spread via lymphatics. 4 In vitro studies have suggested that MR is, in addition to macrophages, abundantly present on both afferent and efferent lymphatics. [5] [6] [7] Furthermore, MR in the lymphatic tissues of human tissue sections is able to bind lymphocytes and certain types of tumor cells. 8, 9 However, lack of function-blocking antibodies against mouse MR and relevant gene-manipulated mice have prevented an evaluation of the role of MR in lymphocyte trafficking in vivo. Recent availability of MR-/-mice allowed us to study the role of lymphatic-associated MR.
Materials and methods

Animals
Specific pathogen free age and sex matched (6 -16 weeks old) wild type (WT) and MR-/-mice (on the C57BL/6 background) were used in the experiments. Production of MR-/-mice has been described earlier. 10 The experiments were approved by the Animal Care
Committee of the University of Turku, permit number 1575/05 and conformed to the guidelines established by the European Union.
Flow cytometry
The phenotype of lymphocytes from WT and MR-/-mice was determined by flow cytometry. In brief, cell suspensions were prepared from the peripheral (axillary and inguinal) lymph nodes, mesenteric lymph nodes, Peyer´s patches, thymus and spleen by using mechanical teasing through a steel mesh. Erythrocytes were lysed from the spleen by a brief hypotonic lysis. Cells were stained with phycoerythrin (PE)-conjugated monoclonal antibodies against CD4, CD8, CD62L (Pharmingen). Biotinylated B220 antibody (TIB146, ATCC, Manassas, VA) followed by PE-conjugated streptavidin was used to detect B cells.
Labelled cells were analyzed by FACScan (BD Biosciences).
Lymphocyte migration via lymphatic vessels
Lymphocyte migration into the draining lymph nodes was measured as described. 11 In brief, cells from peripheral lymph nodes, mesenteric lymph nodes and spleen of WT mice were fluorescently labeled by a 30 min-incubation with 5-chloromethyl fluorescein diacetate (CMFDA, Molecular Probes). After washing, 5x10 6 cells were injected subcutaneously into the left hind footpad of MR -/-mice and WT controls. After 13 h the recipient mice were sacrificed and lymphocyte suspensions were prepared from popliteal lymph nodes. Cells were then stained with alexa Fluor 647-conjugated anti-CD4 mAb, peridinin chlorophyll protein-Cyanine 5,5 (PerCP-Cy5,5)-conjugated anti-CD8 mAb and biotinylated B220 antibody followed by PE-conjugated streptavidin. Migration efficiency was determined as percentage of injected cells (CMFDA-labeled) within lymph node lymphocytes by flow cytometry. The 13 h migration time was pre-tested to be optimal as at were monitored twice a week using bioluminescence imaging as described previously. 12 In brief, mice were anesthetized with 2.5% isoflurane (Becton Dickinson). A substrate for the luciferase (D-luciferin sodium salt, Synchem, Kassel, Germany; 150 mg/kg i.p.) was injected into mice 10 min before imaging. Photographic images were taken in the IVIS imaging station with a cooled CCD camera (IVIS; Xenogen, Alameda, CA). Signal intensities were quantified from regions of interest as photon counts using the Living Image software (Xenogen).
Immunohistochemistry
Acetone fixed frozen sections (5μm) of the ear and peripheral lymph nodes or lymph node metastases of the MR-/-(n=4) and WT (n=4) were stained with polyclonal rabbit antimouse LYVE (Relia Tech) and monoclonal anti-Langerin (CD207; eBioscience) or with negative control mAb or serum (anti-human CD44, Hermes-1 and normal rabbit serum). In addition, ears and lymph nodes of 3 MR-/-and 3 WT mice were stained with goat antimouse CCL21 (R&D Systems), rabbit anti-mouse S1P 1 (Cayman Chemical), rat mAb MECA32 (kind gift from E. Butcher, Stanford University, CA) and rat mAb against mouse CD169, clone 3D6, prepared in house. FITC-conjugated anti-rabbit Ig (Sigma), anti-goat (Sigma) or anti-rat Ig (Sigma) diluted in PBS containing 5% normal mouse serum were used as second stage antibodies. The sections were analyzed using Olympus BX60 microscope. Langerin positive cells were counted in epidermis and dermis in the skin of the ears, in T cell areas of lymph nodes (since they are practically absent from the B cell follicles 13 ) and in primary tumors and metastases. MR expression was analyzed using MR5D3 antibody 14 followed by Alexa-546 conjugated anti-rat Ig in immunofluorescence stainings and peroxidase-conjugated rabbit anti-rat Ig (Dako) in immunoperoxidase stainings. For peroxidase-conjugated secondary reagents, 3,3'-diaminobenzidine in PBS containing 0.03% hydrogen peroxide was used as a chromogen.
Microlymphangiography
The collecting lymphatic vessels were visualized by fluorescent microlymphangiography. 15 In brief, 5 μl of FITC-dextran (MW 2,000,000; 8 mg/ml in PBS; Sigma) was injected into the subepidermal layer in the tip of both ears of 6 normal MR-/-and 6 WT mice. In addition, 6 MR-/-and 6 WT controls were inoculated with B16 melanoma cells into the ear.
After 2 weeks, the animals were used for microlymphangiography as explained above. The ears were examined microscopically with an Olympus BX60 equipped with fluorescence light source (Olympus U-RFL-T). The vessel diameters were analyzed using ImageJ image analysis program (NIH, public domain). The vessel densities were calculated as % of the FITC positive area per field with the same program.
Lymphocyte proliferation assay
The antigen was prepared by lysing B16-luc cells (2x10 6 cell/ml in PBS) by five freezingthawing cycles followed by sonication. 0.5 ml B16-luc cell lysate was injected 
In vitro adhesion and migration assays
Adhesion assays were performed on frozen sections of lymph nodes of MR-/-and WT mice as described. 8 Briefly, mixture of lymphocytes isolated from mesenteric lymph nodes of WT mice and B16 melanoma cells were incubated for 15 min in static conditions, followed (100 ng/ml, R&D), or with 50% of serum of 4 MR -/-or 4 WT mice was added into the lower chamber. After 2 h at 37 o C, the upper chamber was removed and the number of migrated cells in the lower chamber was determined using Tecan Infinite M200.
Statistics
Data were analyzed by the parametric Student's t-tests. Growth curves were analyzed by repeated measures for analyses of variance. Statistical significance was set at p<0,05.
Results
MR on lymphatics regulates the traffic of both B and T cells into the draining lymph nodes
To evaluate the role of MR in lymphocyte migration via afferent lymphatics, we quantified the migration of CMFDA-labeled WT lymphocytes to popliteal lymph nodes following subcutaneous injection into the footpads of both MR-/-and WT mice. We found that the absence of MR significantly impaired the trafficking of CD4 and CD8 positive cells and B cells into the draining lymph nodes ( Figure 1A and B). In contrast, short-term in vivo homing experiments analyzing extravasation of intravenously administered lymphocytes from the blood into several lymphatic organs (peripheral lymph nodes, mesenteric lymph nodes, Peyer's patches and spleen) revealed no significant differences between the genotypes ( Figure 1C ). These results are compatible with the fact that blood vessels are devoid of MR ( Figure 1D ) and show that lymphocyte extravasation is not markedly affected in these mice. Moreover, the proportions of CD4 positive and CD8 positive T cells and B220 positive B cells in the lymphoid organs were virtually identical in MR-deficient and WT animals and even though L-selectin has been shown to be one of the ligands of MR there were no differences in the number of cells expressing this lymphocyte homing receptor (Table 1 ). These data indicate that MR is involved in the trafficking of T and B cells through the afferent lymphatics but not in lymphocyte homing via blood vessels.
MR is responsible for tumor metastasis via lymphatics
Many tumors spread via the lymphatic vessels. 18, 19 To Figure 2B ). In contrast, the metastatic lesions in the draining lymph nodes were much smaller in the MR-/-animals than in the WT controls at the 2 week time point ( Figure 2C ). Similarly the ratio between the sizes of the lymph node metastases and primary tumors was significantly smaller in MR-/-than in the control mice ( Figure 2D ).
Importantly, the overall growth of the tumor foci (primary + metastasis) was not higher in MR-/-than in control mice even though the location of the growth was markedly different ( Figure 2E ). Collectively these data suggest that the lack of MR leads not only to faster growth of the primary tumor but also impairs the formation of metastatic lesions in the draining lymph nodes.
To study whether lymphocytes of MR-/-and control mice respond differently to CCL21 chemokine or whether sera from these animals have different capacity to attract lymphocytes we performed trans-well migration assays. In these assays we did not observe any differences between the lymphocytes or sera of MR-/-and WT mice (data not shown).
These data support the idea that adhesion defects rather than chemotactic alterations are behind the impaired migration of lymphocytes and melanoma cells into the draining lymph nodes.
Tumors of MR-/-and WT mice contain comparable number of dendritic cells
One 
Macrophages of MR-/-are able to normal presentation of tumor antigen
As macrophage mannose receptor is present on macrophages and dendritic cells and could be potentially involved in anti-tumor immune response we analyzed the capacity of peritoneal macrophages to present tumor antigens. After in vivo immunization of MR-/-and WT mice in vitro proliferation assays were performed using different combinations of macrophages and T cells isolated from these mice. These assays showed that lack of MR does not affect the ability of in vivo-primed macrophages to present tumor antigens to T cells ( Figure 3C ).
Normal density and morphology of lymphatics in MR deficient mice
Since MR is present on the lymphatic endothelium, its deletion could affect the structure or fluid-collecting function of the lymphatic vasculature. Immunostaining with LYVE-1, a lymphatic endothelium selective marker, showed that the number and overall morphology of lymphatic vessels were similar in WT and MR-/-animals ( Figure 4A ). The expression patterns of sphingosine 1 phosphate receptor 1 (S1P 1 ) and CCL21, two molecules involved in lymphatic migration, were also indistinguishable between WT and MR-/-mice (Supplemental Figure 1) . In addition expression of CD169/sialoadhesin, identifying macrophages in subcapsular sinus, was similar in both genotypes (Supplemental Figure 1) .
Microlymphangiography with subcutaneously injected, high molecular weight fluorescent dextran also revealed no detectable differences regarding morphology, diameter, location and density of lymphatic vessels between WT and MR-/-animals ( Figure 4B-D) . In tumor bearing ears, the density of the lymphatics was slightly increased.
Practically all lymphatics were peritumoral as no FITC-dextran was visualized within the tumors, but again no differences were evident between the two genotypes ( Figure 4B, C) .
Since the absence of MR did not have marked consequences to the morphology or phenotype of lymphatics, these data support the idea that the deficient trafficking of cells in afferent lymphatics in MR-/-animals is caused by lack of the binding between MR and its counter-receptor on migrating cells.
Adhesion of tumor cells and lymphocytes to lymphatic vessels is compromised in MR-
/-mice
To directly test, whether lack of MR affects the binding of lymphocytes and tumor cells to MR is present on both afferent and efferent lymphatics. 5 Lymphatic sinuses belong to the efferent arm of the lymphatic system and are the exit sites for lymphocytes from the nodes. They are also considered as sieves for arresting cellular debris and microbes. 7 This is well in line with the fact that, especially in the mouse, the lymph node sinuses contain an abundant MR positive macrophage population. 6 Theoretically, it would be possible that these medullary MR positive macrophages are also able to arrest lymphocytes and cancer cells. Our studies favor the idea that MR can serve as an adhesion molecule during cell migration to lymph nodes. We have shown that both lymphocytes and cancer cells bind to lymphatic sinuses in an MR-dependent fashion in vitro. Moreover, in vivo we find no evidence for altered chemotaxis, cell motility or lymph node entrapment in MR-/-mice.
Theoretically, however, it remains possible that some non-adhesion dependent function could explain the observed phenotype. In any case, we believe that cell migration to lymphatics may be a multi-step cascade reminiscent of that seen in the blood vessels and MR is only one step in the continuum of adhesive and chemoattractive events /see below).
Cells may use multiple receptors for binding to MR on lymphatic endothelial cells.
L-selectin, which can bind to MR expressed on efferent lymphatic sinuses in vitro, 8, 20 may also be utilized by L-selectin positive lymphocytes when they leave the peripheral tissues via afferent lymphatics. However, our phenotypic analysis of lymphoid tissues showed no marked differences in L-selectin expression between the WT and MR-/-animals ( Table 1 ).
These data suggest that additional receptors must exist or that lymphocytes utilizing MR- Lymphangiogenesis during development and in pathological conditions in adults has been dissected in great detail during the past few years, and many of the molecules involved have been thoroughly characterized. 19 In contrast, the molecular complexity behind the regulation of cell movement, especially that of lymphocytes, into the lymphatics remains largely unresolved although the importance of lymphatics as an active element in normal leukocyte trafficking and tumor spread is widely accepted.
Recently, several molecular interactions have been reported to contribute to dendritic cell trafficking through afferent lymphatics. [30] [31] [32] [33] [34] Regarding lymphocyte migration within lymphatics, it is known that, besides attracting dendritic cells, chemokine CCL21 present on lymphatic endothelium guides CCR7 positive lymphocytes into the afferent lymphatics and hence to the draining lymph nodes. 11,35 S1P 1 expressed in many different cell types participates in lymphocyte exit from the lymph nodes and regulates emigration of thymocytes from the thymus. [36] [37] [38] [39] Current studies suggest that SIP 1 controls lymphocyte trafficking by regulating endothelial permeability and/or suppressing lymphocyte chemotaxis in SIP gradients. 39 When compared to MR, the molecules so far described to mediate either lymphocyte or dendritic cell trafficking within the lymphatics have notable differences. They are either chemotactic molecules such as SIP 1 , CCL21 and CXCL12
and/or expressed on a wide variety of other cell types in addition to lymphatic endothelium 
